Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
US regulators have approved GlaxoSmithKline's treatment for chronic obstructive pulmonary disease, but the excitement was cooled by news that Denmark has approved the sale of a generic copy of GSK's biggest product, Advair. On Wednesday evening Glaxo and Theravance announced that the US Food and Dr
Read more
By Kate Kelland LONDON, Dec 18 (Reuters) - Scientists have found that the sleep disorder narcolepsy can sometimes be triggered by a scientific phenomenon known as "molecular mimicry", offering a possible explanation for its link to a GlaxoSmithKline H1N1 pandemic flu vaccine. Results
Read more(Refiled to improve headline, no change to text) * Green light generic copy of GSK's $8-billion drug Advair * Danish approval is first for product in Europe * Inhaled medicine developed by Vectura and Sandoz * News overshadows U.S. approval for new GSK drug Anoro * G
Read moreDec 18 (Reuters) - The U.S. Food and Drug Administration approved GlaxoSmithKline Plc's new lung drug for treatment of chronic obstructive pulmonary disease (COPD), commonly known as smoker's lung. However, the inhaled treatment, Anoro Ellipta, will carry a warning that one of its component
Read moreCentrica was the top riser on Wednesday after the energy company said it would sell its Texas gas-fired power stations to Blackstone for 685m dollars and use the proceeds to extend its share buyback programme. Chipmaker ARM Holdings gained after Dixons Retail posted sales growth driven by tablet co
Read moreLONDON, Dec 18 (Reuters) - Vectura said its partner Sandoz had received Danish approval for an inhaled lung drug that analysts widely believe to be a generic version of GlaxoSmithKline's $8 billion-a-year blockbuster Advair. British pharmaceutical company Vectura said in a statement on Wedn
Read moreBerendsen: Panmure Gordon raises target price from 761p to 917p, while retaining its hold recommendation. British American Tabacco: Nomura cuts target price from 3840p to 3720p, while staying with its buy recommendation. bwin.party: Daniel Stewart reduces target price from 173p to 146p, while its
Read moreBy Jim Finkle BOSTON, Dec 17 (Reuters) - The U.S. Food and Drug Administration is under pressure from the pharmaceutical industry and lawmakers to undergo an independent security audit, after hackers broke into a computer system used by healthcare companies to submit information to the agen
Read moreSupermarkets stocks were registering losses on Tuesday afternoon after a report from Kantar Worldpanel revealed that over half the UK shopped in either Aldi or Lidl during the 12 weeks to December 8th for the first time in history. The panel found that all of the Big Four grocers and with the Co-o
Read moreDrug giant GlaxoSmithKline (GSK) is launching a shake-up of its sales and marketing incentives as Chinese officials continue a probe into bribery allegations. GSK is scrapping individual targets for its sales staff and replacing them with a scheme rewarding technical knowledge, service quality and
Read more* GSK scrapping doctor payments for speaking engagements * Ending sales reps' targets globally following U.S. move * Comes amid criticism of aggressive industry sales tactics * Move may pressure other drug companies to follow suit By Ben Hirschler LONDON, Dec 17 (Reu
Read more- US inflation in focus ahead of Fed meeting - German sentiment rises; UK inflation eases - S&P downgrades RSA, Fitch lowers outlook - Cable & Wireless Comms gains on bid speculation techMARK 2,690.49 +0.16% FTSE 100 6,499.13 -0.35% FTSE 250 15,419.43 +0.23% Markets across Europe were trading in t
Read morePerhaps two of the most difficult lessons in Finance are knowing when to cash in your chips and when it´s simply best to walk away. On Wednesday GlaxoSmithKline (GSK) announced its offer to raise its stake in GSK Pharmaceutical, its India drug manufacturing unit, from 50 per cent to 75 per cent. Tha
Read more- Markets pull back after 1.3 per cent surge on Monday - Investors await US inflation data ahead of Fed meeting - RSA hit by two credit ratings downgrades techMARK 2,680.51 -0.21% FTSE 100 6,489.08 -0.51% FTSE 250 15,329.78 -0.36% After a strong surge the day before, UK markets opened with moderat
Read moreAdvanced Medical Solutions: Panmure Gordon downgrades from buy to hold with a target price of 102p. Antofagasta: Canaccord Genuity cuts target price from 1110p to 1035p, while staying with its buy recommendation. ASOS: Panmure Gordon increases target price from 5950p to 6126p, while downgrading fr
Read more
Last checked at